Senior Manager Clinical Biomarker Operations

About Apogee Therapeutics

Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed clinical-stage biotechnology company. We operate in a fast-paced, highly dynamic environment where you can actively contribute to shaping company culture, take on various roles and responsibilities, and grow professionally.

Apogee Therapeutics advances novel biologics with potential for differentiated efficacy and dosing in the largest inflammation and immunology (I&I) markets. Our antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties.

Zumilokibart (APG777), our most advanced program, is being initially developed for the treatment of atopic dermatitis (AD) and asthma. With four validated targets in our portfolio, we are seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of novel antibodies.

Our Culture

We are committed to building an exceptional culture founded on our C.O.R.E. values:

• Caring
• Original
• Resilient
• Egoless

We are committed to refusing to stop at "good enough."